During the past decade, MBAL Sveti Ivan Rilski, Klinika po Gastroenterologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MBAL Sveti Ivan Rilski, Klinika po Gastroenterologia" are "Ulcerative Colitis" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "MBAL Sveti Ivan Rilski, Klinika po Gastroenterologia" in a lesser frequency.

Most popular intervention types in "MBAL Sveti Ivan Rilski, Klinika po Gastroenterologia" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "225mg SHP647 (PF-00547659)" (1 trials), "75mg SHP647 (PF-00547659)" (1 trials), "CP-690,550" (1 trials) and "PF-00547659 SC Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "MBAL Sveti Ivan Rilski, Klinika po Gastroenterologia" are 3 trials for "All" genders.

Currently, there are NaN active trials in "MBAL Sveti Ivan Rilski, Klinika po Gastroenterologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in MBAL Sveti Ivan Rilski, Klinika po Gastroenterologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MBAL Sveti Ivan Rilski, Klinika po Gastroenterologia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".